BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biomed.cas.cz
X-WR-CALDESC:Akce na 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Prague
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Prague:20231120T143000
DTEND;TZID=Europe/Prague:20231120T160000
DTSTAMP:20260419T053417
CREATED:20231115T140331Z
LAST-MODIFIED:20231115T140803Z
UID:718-1700490600-1700496000@www.biomed.cas.cz
SUMMARY:IEM CAS Distinguished Guest Seminar Series - Prof. Jens Pahnke
DESCRIPTION:ABC transporter blood-brain barrier function in neurodegenerative and neuroinflammatory diseases – from basic research to treatment\nLecturer: Prof. Jens Pahnke\, M.D.\, Ph.D.\, E.F.N./ University of Oslo\, Faculty of Medicine / Oslo University Hospital\, Department of Pathology\, Norway \nThe seminar will take place on 20. 11. 2023 from 2:30 p.m. in the Turquoise Auditorium of the IEM CAS. \nAnnotation: \nThe current understanding of neurodegenerative diseases focusses on the deposition of toxic peptide species as larger aggregates in the brain of effected individuals. However\, patients with sporadic neurodegenerative diseases do not overexpress these peptides. Moreover\, they are hampered in removing the physiologically produced peptides\, e.g. Aβ and α-synuclein. The blood-brain barrier plays a prominent role in the active and effective removal of metabolites and in the efflux of toxic peptides from the brain into the blood stream. \nHere\, ABC transporters were discovered by us and others to have a fundamental role in the homeostasis of the brain’s environment. In 2011\, we described a new ABC transporter (ABCC1) that increases Aβ in the brain of knock-out animals by 12-14fold. Since then\, we could show that the activation of ABC transporters can be used as a diagnostic tool and a new treatment option in elderly with Alzheimer’s disease and other neurodegenerative diseases\, such as Huntington’s disease. \n1 Pahnke\, J. et al. Free Neuropathol 2\, 33\, (2021)\n2 Pahnke\, J. et al. Neurobiol Dis 72 Pt A\, 54-60\, (2014)\n3 Pahnke\, J. et al. Curr Alzheimer Res 5\, 396-405\, (2008) \nWe look forward to your participation.
URL:https://www.biomed.cas.cz/event/iem-cas-distinguished-guest-seminar-series-prof-jens-pahnke/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Prague:20231120T150000
DTEND;TZID=Europe/Prague:20231120T160000
DTSTAMP:20260419T053417
CREATED:20231030T111926Z
LAST-MODIFIED:20231030T111926Z
UID:700-1700492400-1700496000@www.biomed.cas.cz
SUMMARY:Lecture
DESCRIPTION:Laboratory of Developmental Epileptology\, IPHYS
URL:https://www.biomed.cas.cz/event/lecture/
END:VEVENT
END:VCALENDAR